Home Menu

Site Navigation



ALS News & Research For postings of news or research links and articles related to ALS


advertisement
NeuroTalk Support Groups > > > >

Rilutek Use, Time to ALS Diagnosis Vary Across Canadian Provinces, Study Shows

Reply
 
Thread Tools Display Modes
Old 11-29-2018, 11:39 AM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,268
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
Post Rilutek Use, Time to ALS Diagnosis Vary Across Canadian Provinces, Study Shows
Rilutek Use, Time to ALS Diagnosis Vary Across Canadian Provinces, Study Shows

Time to ALS Diagnosis, Rilutek Use Vary Across Canada, Study Says

note the median survival is thirty-six months, n=1006.
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
canadian, provinces, rilutek, study, vary

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Study shows physical function declines years before PD diagnosis johnt Parkinson's Disease 0 07-03-2012 09:53 PM
Study Shows How Brain Buys Time For Tough Choices soccertese Parkinson's Disease 3 09-26-2011 05:10 AM


All times are GMT -5. The time now is 09:43 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home